- INJ’s T-Mobile partnership boosts institutional infrastructure narrative; AI token leadership drove prior 12% rally.
- Cross-chain DeFi modules (Ethereum, Cosmos, Solana) attract developers; $11.50–$11.20 risk if $12.25 fails.
Injective (INJ) is currently trading at $12.49, down -8.26% over the last 24 hours and -0.91% over the past 7 days, reflecting a sharp short-term correction following a period of bullish momentum.
With a market capitalization of $1.22 billion, INJ is ranked #86 globally. The current 24-hour trading volume is $117.9 million, though volume has dropped more than 26%, indicating a pullback in speculative trading activity.
Technically, INJ is trading near key support levels around $12.25–$12.40. If this level fails, INJ could retrace toward $11.50–$11.20. On the upside, a breakout above $13.00 with renewed volume could target $14.20–$15.00, especially if sentiment improves and capital rotates back into DeFi tokens.
Recent Market Highlights:
- INJ has completed an inverse head-and-shoulders pattern, with analysts targeting a potential breakout toward $17, should macro and market conditions stabilize.
- Injective is actively expanding its role in the AI token sector, reportedly leading the segment with a recent 12% surge prior to the current pullback.
- A high-profile collaboration between Injective and T-Mobile was announced, aimed at developing an on-chain future for financial applications, boosting the narrative of institutional-grade infrastructure.
Injective remains a key DeFi-focused Layer 1 protocol, with cross-chain compatibility across Ethereum, Cosmos, and Solana ecosystems. It offers modules for building decentralized exchanges, derivatives markets, and synthetic assets — a model that continues to attract developers and institutions alike.
If INJ holds above $12.25 and breaks $13.00 with increased volume, it is projected to reach $14.80–$15.60 within 6–8 days, fueled by Layer 1 DeFi interest, AI infrastructure demand, and bullish technical patterns.
